Organon & Co. (OGN) stock forecast and price target
Price $13.90 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($13.90)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $3.44 | −6.1% | $6.2B |
| Next fiscal year ends December 31, 2027 | $3.65 | +6.2% | $6.3B |
| Next quarter ends December 31, 2026 | $0.95 | +50.2% | $1.5B |
| Quarter after ends March 31, 2027 | $0.92 | +29.8% | $1.5B |
Consensus of the analysts covering Organon &, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.
Our model vs. Wall Street
Analysts see 25.7% downside over 12 months. Our discounted cash flow model with moderate assumptions puts Organon &’s intrinsic value about 93% above today’s market value, and it scores 2.4 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Organon & stock price target?
The average 12-month target from 3 analysts is $10.33, 25.7% below the current price of $13.90 Targets range from $8.00 to $14.00.
Is Organon & a buy according to analysts?
The consensus rating is “None” (3 hold, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.
How much is Organon & expected to earn?
Analysts expect EPS of $3.44 for the fiscal year ending December 31, 2026 and $3.65 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.